30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Spellman David A

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 33% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Spellman David A's trades of Akebia Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-18 2023-05-16
S Sale
59,203 -25.3%
216.91
US$4,179,103 		59,203 -25.3% 216.91 US$4,179,103
2023-05-16 2023-05-16
PrS Proposed sale
43,977
149.42
US$72,043 		43,977 149.42 US$72,043
2023-03-03 2023-03-01
S Sale
51,451 +26.7%
370.03
US$1,600,733 		51,451 +26.7% 370.03 US$1,600,733
2023-03-03 2023-03-01
S Sale
6,400 -1.2%
0.88
US$5,616 		6,400 -1.2% 0.88 US$5,616
2023-03-01 2023-02-27
S Sale
7,539 -1.4%
0.81
US$6,131 		7,539 -1.4% 0.81 US$6,131
2022-03-02 2022-03-01
S Sale
803 -0.6%
2.17
US$1,743 		803 -0.6% 2.17 US$1,743
2022-03-02 2022-02-28
S Sale
7,400 -9.6%
2.15
US$15,946 		7,400 -9.6% 2.15 US$15,946
2021-04-01 2021-04-01
S Sale
790 -1.0%
3.40
US$2,686 		790 -1.0% 3.40 US$2,686